| ||||
Public Act 103-0348 | ||||
| ||||
| ||||
AN ACT concerning education.
| ||||
Be it enacted by the People of the State of Illinois,
| ||||
represented in the General Assembly:
| ||||
Section 5. The School Code is amended by changing Section | ||||
22-30 as follows:
| ||||
(105 ILCS 5/22-30)
| ||||
Sec. 22-30. Self-administration and self-carry of asthma | ||||
medication and epinephrine injectors; administration of | ||||
undesignated epinephrine injectors; administration of an | ||||
opioid antagonist; administration of undesignated asthma | ||||
medication; asthma episode emergency response protocol.
| ||||
(a) For the purpose of this Section only, the following | ||||
terms shall have the meanings set forth below:
| ||||
"Asthma action plan" means a written plan developed with a | ||||
pupil's medical provider to help control the pupil's asthma. | ||||
The goal of an asthma action plan is to reduce or prevent | ||||
flare-ups and emergency department visits through day-to-day | ||||
management and to serve as a student-specific document to be | ||||
referenced in the event of an asthma episode. | ||||
"Asthma episode emergency response protocol" means a | ||||
procedure to provide assistance to a pupil experiencing | ||||
symptoms of wheezing, coughing, shortness of breath, chest | ||||
tightness, or breathing difficulty. |
"Epinephrine injector" includes an auto-injector approved | ||
by the United States Food and Drug Administration for the | ||
administration of epinephrine and a pre-filled syringe | ||
approved by the United States Food and Drug Administration and | ||
used for the administration of epinephrine that contains a | ||
pre-measured dose of epinephrine that is equivalent to the | ||
dosages used in an auto-injector. | ||
"Asthma medication" means quick-relief asthma medication, | ||
including albuterol or other short-acting bronchodilators, | ||
that is approved by the United States Food and Drug | ||
Administration for the treatment of respiratory distress. | ||
"Asthma medication" includes medication delivered through a | ||
device, including a metered dose inhaler with a reusable or | ||
disposable spacer or a nebulizer with a mouthpiece or mask.
| ||
"Opioid antagonist" means a drug that binds to opioid | ||
receptors and blocks or inhibits the effect of opioids acting | ||
on those receptors, including, but not limited to, naloxone | ||
hydrochloride or any other similarly acting drug approved by | ||
the U.S. Food and Drug Administration. | ||
"Respiratory distress" means the perceived or actual | ||
presence of wheezing, coughing, shortness of breath, chest | ||
tightness, breathing difficulty, or any other symptoms | ||
consistent with asthma. Respiratory distress may be | ||
categorized as "mild-to-moderate" or "severe". | ||
"School nurse" means a registered nurse working in a | ||
school with or without licensure endorsed in school nursing. |
"Self-administration" means a pupil's discretionary use of | ||
his or
her prescribed asthma medication or epinephrine | ||
injector.
| ||
"Self-carry" means a pupil's ability to carry his or her | ||
prescribed asthma medication or epinephrine injector. | ||
"Standing protocol" may be issued by (i) a physician | ||
licensed to practice medicine in all its branches, (ii) a | ||
licensed physician assistant with prescriptive authority, or | ||
(iii) a licensed advanced practice registered nurse with | ||
prescriptive authority. | ||
"Trained personnel" means any school employee or volunteer | ||
personnel authorized in Sections 10-22.34, 10-22.34a, and | ||
10-22.34b of this Code who has completed training under | ||
subsection (g) of this Section to recognize and respond to | ||
anaphylaxis, an opioid overdose, or respiratory distress. | ||
"Undesignated asthma medication" means asthma medication | ||
prescribed in the name of a school district, public school, | ||
charter school, or nonpublic school. | ||
"Undesignated epinephrine injector" means an epinephrine | ||
injector prescribed in the name of a school district, public | ||
school, charter school, or nonpublic school. | ||
(b) A school, whether public, charter, or nonpublic, must | ||
permit the
self-administration and self-carry of asthma
| ||
medication by a pupil with asthma or the self-administration | ||
and self-carry of an epinephrine injector by a pupil, provided | ||
that:
|
(1) the parents or
guardians of the pupil provide to | ||
the school (i) written
authorization from the parents or | ||
guardians for (A) the self-administration and self-carry | ||
of asthma medication or (B) the self-carry of asthma | ||
medication or (ii) for (A) the self-administration and | ||
self-carry of an epinephrine injector or (B) the | ||
self-carry of an epinephrine injector, written | ||
authorization from the pupil's physician, physician | ||
assistant, or advanced practice registered nurse; and
| ||
(2) the
parents or guardians of the pupil provide to | ||
the school (i) the prescription label, which must contain | ||
the name of the asthma medication, the prescribed dosage, | ||
and the time at which or circumstances under which the | ||
asthma medication is to be administered, or (ii) for the | ||
self-administration or self-carry of an epinephrine | ||
injector, a
written
statement from the pupil's physician, | ||
physician assistant, or advanced practice registered
nurse | ||
containing
the following information:
| ||
(A) the name and purpose of the epinephrine | ||
injector;
| ||
(B) the prescribed dosage; and
| ||
(C) the time or times at which or the special | ||
circumstances
under which the epinephrine injector is | ||
to be administered.
| ||
The information provided shall be kept on file in the office of | ||
the school
nurse or,
in the absence of a school nurse, the |
school's administrator.
| ||
(b-5) A school district, public school, charter school, or | ||
nonpublic school may authorize the provision of a | ||
student-specific or undesignated epinephrine injector to a | ||
student or any personnel authorized under a student's | ||
Individual Health Care Action Plan, Illinois Food Allergy | ||
Emergency Action Plan and Treatment Authorization Form, or | ||
plan pursuant to Section 504 of the federal Rehabilitation Act | ||
of 1973 to administer an epinephrine injector to the student, | ||
that meets the student's prescription on file. | ||
(b-10) The school district, public school, charter school, | ||
or nonpublic school may authorize a school nurse or trained | ||
personnel to do the following: (i) provide an undesignated | ||
epinephrine injector to a student for self-administration only | ||
or any personnel authorized under a student's Individual | ||
Health Care Action Plan, Illinois Food Allergy Emergency | ||
Action Plan and Treatment Authorization Form, plan pursuant to | ||
Section 504 of the federal Rehabilitation Act of 1973, or | ||
individualized education program plan to administer to the | ||
student that meets the student's prescription on file; (ii) | ||
administer an undesignated epinephrine injector that meets the | ||
prescription on file to any student who has an Individual | ||
Health Care Action Plan, Illinois Food Allergy Emergency | ||
Action Plan and Treatment Authorization Form, plan pursuant to | ||
Section 504 of the federal Rehabilitation Act of 1973, or | ||
individualized education program plan that authorizes the use |
of an epinephrine injector; (iii) administer an undesignated | ||
epinephrine injector to any person that the school nurse or | ||
trained personnel in good faith believes is having an | ||
anaphylactic reaction; (iv) administer an opioid antagonist to | ||
any person that the school nurse or trained personnel in good | ||
faith believes is having an opioid overdose; (v) provide | ||
undesignated asthma medication to a student for | ||
self-administration only or to any personnel authorized under | ||
a student's Individual Health Care Action Plan or asthma | ||
action plan, plan pursuant to Section 504 of the federal | ||
Rehabilitation Act of 1973, or individualized education | ||
program plan to administer to the student that meets the | ||
student's prescription on file; (vi) administer undesignated | ||
asthma medication that meets the prescription on file to any | ||
student who has an Individual Health Care Action Plan or | ||
asthma action plan, plan pursuant to Section 504 of the | ||
federal Rehabilitation Act of 1973, or individualized | ||
education program plan that authorizes the use of asthma | ||
medication; and (vii) administer undesignated asthma | ||
medication to any person that the school nurse or trained | ||
personnel believes in good faith is having respiratory | ||
distress. | ||
(c) The school district, public school, charter school, or | ||
nonpublic school must inform the parents or
guardians of the
| ||
pupil, in writing, that the school district, public school, | ||
charter school, or nonpublic school and its
employees and
|
agents, including a physician, physician assistant, or | ||
advanced practice registered nurse providing standing protocol | ||
and a prescription for school epinephrine injectors, an opioid | ||
antagonist, or undesignated asthma medication,
are to incur no | ||
liability or professional discipline, except for willful and | ||
wanton conduct, as a result
of any injury arising from the
| ||
administration of asthma medication, an epinephrine injector, | ||
or an opioid antagonist regardless of whether authorization | ||
was given by the pupil's parents or guardians or by the pupil's | ||
physician, physician assistant, or advanced practice | ||
registered nurse. The parents or guardians
of the pupil must | ||
sign a statement acknowledging that the school district, | ||
public school, charter school,
or nonpublic school and its | ||
employees and agents are to incur no liability, except for | ||
willful and wanton
conduct, as a result of any injury arising
| ||
from the
administration of asthma medication, an epinephrine | ||
injector, or an opioid antagonist regardless of whether | ||
authorization was given by the pupil's parents or guardians or | ||
by the pupil's physician, physician assistant, or advanced | ||
practice registered nurse and that the parents or
guardians | ||
must indemnify and hold harmless the school district, public | ||
school, charter school, or nonpublic
school and
its
employees | ||
and agents against any claims, except a claim based on willful | ||
and
wanton conduct, arising out of the
administration of | ||
asthma medication, an epinephrine injector, or an opioid | ||
antagonist regardless of whether authorization was given by |
the pupil's parents or guardians or by the pupil's physician, | ||
physician assistant, or advanced practice registered nurse. | ||
(c-5) When a school nurse or trained personnel administers | ||
an undesignated epinephrine injector to a person whom the | ||
school nurse or trained personnel in good faith believes is | ||
having an anaphylactic reaction, administers an opioid | ||
antagonist to a person whom the school nurse or trained | ||
personnel in good faith believes is having an opioid overdose, | ||
or administers undesignated asthma medication to a person whom | ||
the school nurse or trained personnel in good faith believes | ||
is having respiratory distress, notwithstanding the lack of | ||
notice to the parents or guardians of the pupil or the absence | ||
of the parents or guardians signed statement acknowledging no | ||
liability, except for willful and wanton conduct, the school | ||
district, public school, charter school, or nonpublic school | ||
and its employees and agents, and a physician, a physician | ||
assistant, or an advanced practice registered nurse providing | ||
standing protocol and a prescription for undesignated | ||
epinephrine injectors, an opioid antagonist, or undesignated | ||
asthma medication, are to incur no liability or professional | ||
discipline, except for willful and wanton conduct, as a result | ||
of any injury arising from the use of an undesignated | ||
epinephrine injector, the use of an opioid antagonist, or the | ||
use of undesignated asthma medication, regardless of whether | ||
authorization was given by the pupil's parents or guardians or | ||
by the pupil's physician, physician assistant, or advanced |
practice registered nurse.
| ||
(d) The permission for self-administration and self-carry | ||
of asthma medication or the self-administration and self-carry | ||
of an epinephrine injector is effective
for the school year | ||
for which it is granted and shall be renewed each
subsequent | ||
school year upon fulfillment of the requirements of this
| ||
Section.
| ||
(e) Provided that the requirements of this Section are | ||
fulfilled, a
pupil with asthma may self-administer and | ||
self-carry his or her asthma medication or a pupil may | ||
self-administer and self-carry an epinephrine injector (i) | ||
while in
school, (ii) while at a school-sponsored activity, | ||
(iii) while under the
supervision of
school personnel, or (iv) | ||
before or after normal school activities, such
as while in | ||
before-school or after-school care on school-operated
property | ||
or while being transported on a school bus.
| ||
(e-5) Provided that the requirements of this Section are | ||
fulfilled, a school nurse or trained personnel may administer | ||
an undesignated epinephrine injector to any person whom the | ||
school nurse or trained personnel in good faith believes to be | ||
having an anaphylactic reaction (i) while in school, (ii) | ||
while at a school-sponsored activity, (iii) while under the | ||
supervision of school personnel, or (iv) before or after | ||
normal school activities, such
as while in before-school or | ||
after-school care on school-operated property or while being | ||
transported on a school bus. A school nurse or trained |
personnel may carry undesignated epinephrine injectors on his | ||
or her person while in school or at a school-sponsored | ||
activity. | ||
(e-10) Provided that the requirements of this Section are | ||
fulfilled, a school nurse or trained personnel may administer | ||
an opioid antagonist to any person whom the school nurse or | ||
trained personnel in good faith believes to be having an | ||
opioid overdose (i) while in school, (ii) while at a | ||
school-sponsored activity, (iii) while under the supervision | ||
of school personnel, or (iv) before or after normal school | ||
activities, such as while in before-school or after-school | ||
care on school-operated property. A school nurse or trained | ||
personnel may carry an opioid antagonist on his or her person | ||
while in school or at a school-sponsored activity. | ||
(e-15) If the requirements of this Section are met, a | ||
school nurse or trained personnel may administer undesignated | ||
asthma medication to any person whom the school nurse or | ||
trained personnel in good faith believes to be experiencing | ||
respiratory distress (i) while in school, (ii) while at a | ||
school-sponsored activity, (iii) while under the supervision | ||
of school personnel, or (iv) before or after normal school | ||
activities, including before-school or after-school care on | ||
school-operated property. A school nurse or trained personnel | ||
may carry undesignated asthma medication on his or her person | ||
while in school or at a school-sponsored activity. | ||
(f) The school district, public school, charter school, or |
nonpublic school may maintain a supply of undesignated | ||
epinephrine injectors in any secure location that is | ||
accessible before, during, and after school where an allergic | ||
person is most at risk, including, but not limited to, | ||
classrooms and lunchrooms. A physician, a physician assistant | ||
who has prescriptive authority in accordance with Section 7.5 | ||
of the Physician Assistant Practice Act of 1987, or an | ||
advanced practice registered nurse who has prescriptive | ||
authority in accordance with Section 65-40 of the Nurse | ||
Practice Act may prescribe undesignated epinephrine injectors | ||
in the name of the school district, public school, charter | ||
school, or nonpublic school to be maintained for use when | ||
necessary. Any supply of epinephrine injectors shall be | ||
maintained in accordance with the manufacturer's instructions. | ||
The school district, public school, charter school, or | ||
nonpublic school shall may maintain a supply of an opioid | ||
antagonist in any secure location where an individual may have | ||
an opioid overdose , unless there is a shortage of opioid | ||
antagonists, in which case the school district, public school, | ||
charter school, or nonpublic school shall make a reasonable | ||
effort to maintain a supply of an opioid antagonist . Unless | ||
the school district, public school, charter school, or | ||
nonpublic school is able to obtain opioid antagonists without | ||
a prescription, a A health care professional who has been | ||
delegated prescriptive authority for opioid antagonists in | ||
accordance with Section 5-23 of the Substance Use Disorder Act |
shall may prescribe opioid antagonists in the name of the | ||
school district, public school, charter school, or nonpublic | ||
school, to be maintained for use when necessary. Any supply of | ||
opioid antagonists shall be maintained in accordance with the | ||
manufacturer's instructions. | ||
The school district, public school, charter school, or | ||
nonpublic school may maintain a supply of asthma medication in | ||
any secure location that is accessible before, during, or | ||
after school where a person is most at risk, including, but not | ||
limited to, a classroom or the nurse's office. A physician, a | ||
physician assistant who has prescriptive authority under | ||
Section 7.5 of the Physician Assistant Practice Act of 1987, | ||
or an advanced practice registered nurse who has prescriptive | ||
authority under Section 65-40 of the Nurse Practice Act may | ||
prescribe undesignated asthma medication in the name of the | ||
school district, public school, charter school, or nonpublic | ||
school to be maintained for use when necessary. Any supply of | ||
undesignated asthma medication must be maintained in | ||
accordance with the manufacturer's instructions. | ||
(f-3) Whichever entity initiates the process of obtaining | ||
undesignated epinephrine injectors and providing training to | ||
personnel for carrying and administering undesignated | ||
epinephrine injectors shall pay for the costs of the | ||
undesignated epinephrine injectors. | ||
(f-5) Upon any administration of an epinephrine injector, | ||
a school district, public school, charter school, or nonpublic |
school must immediately activate the EMS system and notify the | ||
student's parent, guardian, or emergency contact, if known. | ||
Upon any administration of an opioid antagonist, a school | ||
district, public school, charter school, or nonpublic school | ||
must immediately activate the EMS system and notify the | ||
student's parent, guardian, or emergency contact, if known. | ||
(f-10) Within 24 hours of the administration of an | ||
undesignated epinephrine injector, a school district, public | ||
school, charter school, or nonpublic school must notify the | ||
physician, physician assistant, or advanced practice | ||
registered nurse who provided the standing protocol and a | ||
prescription for the undesignated epinephrine injector of its | ||
use. | ||
Within 24 hours after the administration of an opioid | ||
antagonist, a school district, public school, charter school, | ||
or nonpublic school must notify the health care professional | ||
who provided the prescription for the opioid antagonist of its | ||
use. | ||
Within 24 hours after the administration of undesignated | ||
asthma medication, a school district, public school, charter | ||
school, or nonpublic school must notify the student's parent | ||
or guardian or emergency contact, if known, and the physician, | ||
physician assistant, or advanced practice registered nurse who | ||
provided the standing protocol and a prescription for the | ||
undesignated asthma medication of its use. The district or | ||
school must follow up with the school nurse, if available, and |
may, with the consent of the child's parent or guardian, | ||
notify the child's health care provider of record, as | ||
determined under this Section, of its use. | ||
(g) Prior to the administration of an undesignated | ||
epinephrine injector, trained personnel must submit to the | ||
school's administration proof of completion of a training | ||
curriculum to recognize and respond to anaphylaxis that meets | ||
the requirements of subsection (h) of this Section. Training | ||
must be completed annually. The school district, public | ||
school, charter school, or nonpublic school must maintain | ||
records related to the training curriculum and trained | ||
personnel. | ||
Prior to the administration of an opioid antagonist, | ||
trained personnel must submit to the school's administration | ||
proof of completion of a training curriculum to recognize and | ||
respond to an opioid overdose, which curriculum must meet the | ||
requirements of subsection (h-5) of this Section. Training | ||
must be completed annually. Trained personnel must also submit | ||
to the school's administration proof of cardiopulmonary | ||
resuscitation and automated external defibrillator | ||
certification. The school district, public school, charter | ||
school, or nonpublic school must maintain records relating to | ||
the training curriculum and the trained personnel. | ||
Prior to the administration of undesignated asthma | ||
medication, trained personnel must submit to the school's | ||
administration proof of completion of a training curriculum to |
recognize and respond to respiratory distress, which must meet | ||
the requirements of subsection (h-10) of this Section. | ||
Training must be completed annually, and the school district, | ||
public school, charter school, or nonpublic school must | ||
maintain records relating to the training curriculum and the | ||
trained personnel. | ||
(h) A training curriculum to recognize and respond to | ||
anaphylaxis, including the administration of an undesignated | ||
epinephrine injector, may be conducted online or in person. | ||
Training shall include, but is not limited to: | ||
(1) how to recognize signs and symptoms of an allergic | ||
reaction, including anaphylaxis; | ||
(2) how to administer an epinephrine injector; and | ||
(3) a test demonstrating competency of the knowledge | ||
required to recognize anaphylaxis and administer an | ||
epinephrine injector. | ||
Training may also include, but is not limited to: | ||
(A) a review of high-risk areas within a school and | ||
its related facilities; | ||
(B) steps to take to prevent exposure to allergens; | ||
(C) emergency follow-up procedures, including the | ||
importance of calling 9-1-1 or, if 9-1-1 is not available, | ||
other local emergency medical services; | ||
(D) how to respond to a student with a known allergy, | ||
as well as a student with a previously unknown allergy; | ||
(E) other criteria as determined in rules adopted |
pursuant to this Section; and | ||
(F) any policy developed by the State Board of | ||
Education under Section 2-3.190. | ||
In consultation with statewide professional organizations | ||
representing physicians licensed to practice medicine in all | ||
of its branches, registered nurses, and school nurses, the | ||
State Board of Education shall make available resource | ||
materials consistent with criteria in this subsection (h) for | ||
educating trained personnel to recognize and respond to | ||
anaphylaxis. The State Board may take into consideration the | ||
curriculum on this subject developed by other states, as well | ||
as any other curricular materials suggested by medical experts | ||
and other groups that work on life-threatening allergy issues. | ||
The State Board is not required to create new resource | ||
materials. The State Board shall make these resource materials | ||
available on its Internet website. | ||
(h-5) A training curriculum to recognize and respond to an | ||
opioid overdose, including the administration of an opioid | ||
antagonist, may be conducted online or in person. The training | ||
must comply with any training requirements under Section 5-23 | ||
of the Substance Use Disorder Act and the corresponding rules. | ||
It must include, but is not limited to: | ||
(1) how to recognize symptoms of an opioid overdose; | ||
(2) information on drug overdose prevention and | ||
recognition; | ||
(3) how to perform rescue breathing and resuscitation; |
(4) how to respond to an emergency involving an opioid | ||
overdose; | ||
(5) opioid antagonist dosage and administration; | ||
(6) the importance of calling 9-1-1 or, if 9-1-1 is | ||
not available, other local emergency medical services; | ||
(7) care for the overdose victim after administration | ||
of the overdose antagonist; | ||
(8) a test demonstrating competency of the knowledge | ||
required to recognize an opioid overdose and administer a | ||
dose of an opioid antagonist; and | ||
(9) other criteria as determined in rules adopted | ||
pursuant to this Section. | ||
(h-10) A training curriculum to recognize and respond to | ||
respiratory distress, including the administration of | ||
undesignated asthma medication, may be conducted online or in | ||
person. The training must include, but is not limited to: | ||
(1) how to recognize symptoms of respiratory distress | ||
and how to distinguish respiratory distress from | ||
anaphylaxis; | ||
(2) how to respond to an emergency involving | ||
respiratory distress; | ||
(3) asthma medication dosage and administration; | ||
(4) the importance of calling 9-1-1 or, if 9-1-1 is | ||
not available, other local emergency medical services; | ||
(5) a test demonstrating competency of the knowledge | ||
required to recognize respiratory distress and administer |
asthma medication; and | ||
(6) other criteria as determined in rules adopted | ||
under this Section. | ||
(i) Within 3 days after the administration of an | ||
undesignated epinephrine injector by a school nurse, trained | ||
personnel, or a student at a school or school-sponsored | ||
activity, the school must report to the State Board of | ||
Education in a form and manner prescribed by the State Board | ||
the following information: | ||
(1) age and type of person receiving epinephrine | ||
(student, staff, visitor); | ||
(2) any previously known diagnosis of a severe | ||
allergy; | ||
(3) trigger that precipitated allergic episode; | ||
(4) location where symptoms developed; | ||
(5) number of doses administered; | ||
(6) type of person administering epinephrine (school | ||
nurse, trained personnel, student); and | ||
(7) any other information required by the State Board. | ||
If a school district, public school, charter school, or | ||
nonpublic school maintains or has an independent contractor | ||
providing transportation to students who maintains a supply of | ||
undesignated epinephrine injectors, then the school district, | ||
public school, charter school, or nonpublic school must report | ||
that information to the State Board of Education upon adoption | ||
or change of the policy of the school district, public school, |
charter school, nonpublic school, or independent contractor, | ||
in a manner as prescribed by the State Board. The report must | ||
include the number of undesignated epinephrine injectors in | ||
supply. | ||
(i-5) Within 3 days after the administration of an opioid | ||
antagonist by a school nurse or trained personnel, the school | ||
must report to the State Board of Education, in a form and | ||
manner prescribed by the State Board, the following | ||
information: | ||
(1) the age and type of person receiving the opioid | ||
antagonist (student, staff, or visitor); | ||
(2) the location where symptoms developed; | ||
(3) the type of person administering the opioid | ||
antagonist (school nurse or trained personnel); and | ||
(4) any other information required by the State Board. | ||
(i-10) Within 3 days after the administration of | ||
undesignated asthma medication by a school nurse, trained | ||
personnel, or a student at a school or school-sponsored | ||
activity, the school must report to the State Board of | ||
Education, on a form and in a manner prescribed by the State | ||
Board of Education, the following information: | ||
(1) the age and type of person receiving the asthma | ||
medication (student, staff, or visitor); | ||
(2) any previously known diagnosis of asthma for the | ||
person; | ||
(3) the trigger that precipitated respiratory |
distress, if identifiable; | ||
(4) the location of where the symptoms developed; | ||
(5) the number of doses administered; | ||
(6) the type of person administering the asthma | ||
medication (school nurse, trained personnel, or student); | ||
(7) the outcome of the asthma medication | ||
administration; and | ||
(8)
any other information required by the State Board. | ||
(j) By October 1, 2015 and every year thereafter, the | ||
State Board of Education shall submit a report to the General | ||
Assembly identifying the frequency and circumstances of | ||
undesignated epinephrine and undesignated asthma medication | ||
administration during the preceding academic year. Beginning | ||
with the 2017 report, the report shall also contain | ||
information on which school districts, public schools, charter | ||
schools, and nonpublic schools maintain or have independent | ||
contractors providing transportation to students who maintain | ||
a supply of undesignated epinephrine injectors. This report | ||
shall be published on the State Board's Internet website on | ||
the date the report is delivered to the General Assembly. | ||
(j-5) Annually, each school district, public school, | ||
charter school, or nonpublic school shall request an asthma | ||
action plan from the parents or guardians of a pupil with | ||
asthma. If provided, the asthma action plan must be kept on | ||
file in the office of the school nurse or, in the absence of a | ||
school nurse, the school administrator. Copies of the asthma |
action plan may be distributed to appropriate school staff who | ||
interact with the pupil on a regular basis, and, if | ||
applicable, may be attached to the pupil's federal Section 504 | ||
plan or individualized education program plan. | ||
(j-10) To assist schools with emergency response | ||
procedures for asthma, the State Board of Education, in | ||
consultation with statewide professional organizations with | ||
expertise in asthma management and a statewide organization | ||
representing school administrators, shall develop a model | ||
asthma episode emergency response protocol before September 1, | ||
2016. Each school district, charter school, and nonpublic | ||
school shall adopt an asthma episode emergency response | ||
protocol before January 1, 2017 that includes all of the | ||
components of the State Board's model protocol. | ||
(j-15) Every 2 years, school personnel who work with | ||
pupils shall complete an in-person or online training program | ||
on the management of asthma, the prevention of asthma | ||
symptoms, and emergency response in the school setting. In | ||
consultation with statewide professional organizations with | ||
expertise in asthma management, the State Board of Education | ||
shall make available resource materials for educating school | ||
personnel about asthma and emergency response in the school | ||
setting. | ||
(j-20) On or before October 1, 2016 and every year | ||
thereafter, the State Board of Education shall submit a report | ||
to the General Assembly and the Department of Public Health |
identifying the frequency and circumstances of opioid | ||
antagonist administration during the preceding academic year. | ||
This report shall be published on the State Board's Internet | ||
website on the date the report is delivered to the General | ||
Assembly. | ||
(k) The State Board of Education may adopt rules necessary | ||
to implement this Section. | ||
(l) Nothing in this Section shall limit the amount of | ||
epinephrine injectors that any type of school or student may | ||
carry or maintain a supply of. | ||
(Source: P.A. 101-81, eff. 7-12-19; 102-413, eff. 8-20-21; | ||
102-813, eff. 5-13-22.)
|